Connor, Clark & Lunn Investment Management (CC&L)’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Buy |
1,066,396
+372,035
| +54% | +$1.4M | 0.01% | 644 |
|
|
2025
Q1 | $3.15M | Buy |
694,361
+439,599
| +173% | +$1.99M | 0.01% | 610 |
|
|
2024
Q4 | $1.8M | Buy |
254,762
+123,230
| +94% | +$871K | 0.01% | 757 |
|
|
2024
Q3 | $1.07M | Buy |
131,532
+71,201
| +118% | +$580K | 0.01% | 864 |
|
|
2024
Q2 | $386K | Sell |
60,331
-10,631
| -15% | -$67.9K | ﹤0.01% | 1117 |
|
|
2024
Q1 | $534K | Buy |
70,962
+12,545
| +21% | +$94.5K | ﹤0.01% | 1086 |
|
|
2023
Q4 | $541K | Buy |
+58,417
| New | +$541K | ﹤0.01% | 1024 |
|
|
2023
Q2 | – | Sell |
-15,433
| Closed | -$180K | – | 1388 |
|
|
2023
Q1 | $180K | Sell |
15,433
-69,443
| -82% | -$810K | ﹤0.01% | 1110 |
|
|
2022
Q4 | $902K | Sell |
84,876
-56,450
| -40% | -$600K | 0.01% | 730 |
|
|
2022
Q3 | $1.37M | Sell |
141,326
-18,798
| -12% | -$182K | 0.01% | 582 |
|
|
2022
Q2 | $2.32M | Buy |
160,124
+149,001
| +1,340% | +$2.16M | 0.01% | 446 |
|
|
2022
Q1 | $291K | Buy |
+11,123
| New | +$291K | ﹤0.01% | 882 |
|